WallStSmart

DR Horton Inc (DHI)vsLennar Corporation (LEN-B)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DR Horton Inc generates 1% more annual revenue ($33.52B vs $33.17B). DHI leads profitability with a 9.9% profit margin vs 5.4%. DHI appears more attractively valued with a PEG of 1.09. DHI earns a higher WallStSmart Score of 55/100 (C).

DHI

Buy

55

out of 100

Grade: C

Growth: 4.7Profit: 6.0Value: 7.3Quality: 7.3
Piotroski: 3/9Altman Z: 5.10

LEN-B

Hold

42

out of 100

Grade: D

Growth: 4.7Profit: 5.0Value: 4.7Quality: 8.5
Piotroski: 3/9Altman Z: 3.66
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DHISignificantly Overvalued (-119.0%)

Margin of Safety

-119.0%

Fair Value

$74.80

Current Price

$133.12

$58.32 premium

UndervaluedFair: $74.80Overvalued
LEN-BSignificantly Overvalued (-137.3%)

Margin of Safety

-137.3%

Fair Value

$47.26

Current Price

$86.28

$39.02 premium

UndervaluedFair: $47.26Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHI3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
5.1010/10

Safe zone — low bankruptcy risk

P/E RatioValuation
12.1x8/10

Attractively priced relative to earnings

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

LEN-B5 strengths · Avg: 9.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
3.6610/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.299/10

Conservative balance sheet, low leverage

P/E RatioValuation
12.7x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$1.67B8/10

Generating 1.7B in free cash flow

Areas to Watch

DHI3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-9.5%2/10

Revenue declined 9.5%

EPS GrowthGrowth
-22.2%2/10

Earnings declined 22.2%

LEN-B4 concerns · Avg: 2.8/10
Profit MarginProfitability
5.4%3/10

5.4% margin — thin

Operating MarginProfitability
3.7%3/10

Operating margin of 3.7%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.022/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : DHI

The strongest argument for DHI centers on Altman Z-Score, P/E Ratio, Price/Book. PEG of 1.09 suggests the stock is reasonably priced for its growth.

Bull Case : LEN-B

The strongest argument for LEN-B centers on Price/Book, Altman Z-Score, Debt/Equity.

Bear Case : DHI

The primary concerns for DHI are Piotroski F-Score, Revenue Growth, EPS Growth.

Bear Case : LEN-B

The primary concerns for LEN-B are Profit Margin, Operating Margin, Piotroski F-Score.

Key Dynamics to Monitor

DHI carries more volatility with a beta of 1.41 — expect wider price swings.

DHI is growing revenue faster at -9.5% — sustainability is the question.

LEN-B generates stronger free cash flow (1.7B), providing more financial flexibility.

Monitor RESIDENTIAL CONSTRUCTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DHI scores higher overall (55/100 vs 42/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DR Horton Inc

CONSUMER CYCLICAL · RESIDENTIAL CONSTRUCTION · USA

D.R. Horton, Inc. is a home construction company incorporated in Delaware and headquartered in Arlington, Texas.

Lennar Corporation

CONSUMER CYCLICAL · RESIDENTIAL CONSTRUCTION · USA

Lennar Corporation is a home construction and real estate company based in Fontainebleau, Florida.

Visit Website →

Want to dig deeper into these stocks?